Kovai Medical Center and Hospital Limited (BOM:523323)
India · Delayed Price · Currency is INR 5,402.05
+47.70 (0.89%)
At close: Jan 22, 2026
BOM:523323 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 14,779 | 13,711 | 12,196 | 10,197 | 9,053 | 6,904 | Upgrade | |
Revenue Growth (YoY) | 13.57% | 12.43% | 19.59% | 12.64% | 31.14% | -3.00% | Upgrade |
Cost of Revenue | 7,300 | 6,798 | 5,968 | 5,060 | 4,446 | 3,407 | Upgrade |
Gross Profit | 7,479 | 6,913 | 6,228 | 5,138 | 4,608 | 3,496 | Upgrade |
Selling, General & Admin | 2,162 | 2,018 | 1,845 | 1,582 | 52.22 | 41.25 | Upgrade |
Other Operating Expenses | 1,141 | 1,029 | 961.81 | 848.63 | 1,978 | 1,522 | Upgrade |
Operating Expenses | 4,321 | 4,023 | 3,728 | 3,322 | 2,884 | 2,244 | Upgrade |
Operating Income | 3,158 | 2,890 | 2,499 | 1,816 | 1,724 | 1,253 | Upgrade |
Interest Expense | -356.83 | -326.39 | -327.5 | -399.33 | -428.66 | -306.92 | Upgrade |
Interest & Investment Income | 183.17 | 183.17 | 161.19 | 99.26 | 87.87 | 76.58 | Upgrade |
Other Non Operating Income (Expenses) | 61.71 | 37.5 | 45.92 | 58.03 | 33.24 | 33.34 | Upgrade |
EBT Excluding Unusual Items | 3,046 | 2,784 | 2,379 | 1,574 | 1,416 | 1,056 | Upgrade |
Gain (Loss) on Sale of Assets | -8.69 | -8.69 | -3.23 | -21.66 | -9.33 | 1.58 | Upgrade |
Pretax Income | 3,037 | 2,776 | 2,376 | 1,552 | 1,407 | 1,057 | Upgrade |
Income Tax Expense | 751.29 | 686.07 | 578.26 | 394.54 | 364.18 | 280.51 | Upgrade |
Net Income | 2,286 | 2,089 | 1,797 | 1,158 | 1,043 | 776.85 | Upgrade |
Net Income to Common | 2,286 | 2,089 | 1,797 | 1,158 | 1,043 | 776.85 | Upgrade |
Net Income Growth | 13.32% | 16.25% | 55.25% | 11.04% | 34.21% | -17.87% | Upgrade |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 11 | Upgrade |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 11 | Upgrade |
EPS (Basic) | 208.91 | 190.96 | 164.26 | 105.80 | 95.28 | 71.00 | Upgrade |
EPS (Diluted) | 208.91 | 190.96 | 164.26 | 105.80 | 95.28 | 71.00 | Upgrade |
EPS Growth | 13.31% | 16.25% | 55.25% | 11.04% | 34.21% | -17.87% | Upgrade |
Free Cash Flow | 1,212 | -1.85 | 2,057 | 1,355 | 1,625 | 48.19 | Upgrade |
Free Cash Flow Per Share | 110.76 | -0.17 | 188.00 | 123.85 | 148.53 | 4.40 | Upgrade |
Dividend Per Share | - | 10.000 | 10.000 | 5.000 | 3.000 | 3.000 | Upgrade |
Dividend Growth | - | - | 100.00% | 66.67% | - | - | Upgrade |
Gross Margin | 50.60% | 50.42% | 51.07% | 50.38% | 50.90% | 50.64% | Upgrade |
Operating Margin | 21.37% | 21.08% | 20.49% | 17.81% | 19.04% | 18.15% | Upgrade |
Profit Margin | 15.47% | 15.24% | 14.74% | 11.35% | 11.52% | 11.25% | Upgrade |
Free Cash Flow Margin | 8.20% | -0.01% | 16.87% | 13.29% | 17.95% | 0.70% | Upgrade |
EBITDA | 4,128 | 3,817 | 3,372 | 2,660 | 2,534 | 1,894 | Upgrade |
EBITDA Margin | 27.93% | 27.84% | 27.65% | 26.09% | 27.99% | 27.43% | Upgrade |
D&A For EBITDA | 969.72 | 927.12 | 872.6 | 844.17 | 810.78 | 640.96 | Upgrade |
EBIT | 3,158 | 2,890 | 2,499 | 1,816 | 1,724 | 1,253 | Upgrade |
EBIT Margin | 21.37% | 21.08% | 20.49% | 17.81% | 19.04% | 18.15% | Upgrade |
Effective Tax Rate | 24.74% | 24.72% | 24.34% | 25.42% | 25.89% | 26.53% | Upgrade |
Revenue as Reported | 15,025 | 13,932 | 12,405 | 10,357 | 9,178 | 7,022 | Upgrade |
Advertising Expenses | - | 94.32 | 82.6 | - | - | - | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.